New implant could replace monthly shots for opioid addiction
Disease control
Not yet recruiting
This study tests an implant called iSTEP-N that releases naltrexone over many months to block opioids. It involves 33 healthy adults aged 18-55, comparing two implant doses to monthly Vivitrol injections. The goal is to see if the implant can provide steady medication levels and …
Phase: PHASE1 • Sponsor: Akyso Therapeutics, LLC • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC